Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000548264 | SCV000642028 | uncertain significance | MHC class I deficiency | 2018-11-01 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs779844691, ExAC 0.001%). This variant has not been reported in the literature in individuals with TAP1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces methionine with leucine at codon 434 of the TAP1 protein (p.Met434Leu). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and leucine. |